Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanju Zhang

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Statistics in Medicine|November 20, 2018
On the efficiency of adaptive sample size designLu Cui, Lanju Zhang
Journal of Biopharmaceutical Statistics|October 31, 2014
One- and two-stage Arrhenius models for pharmaceutical shelf life predictionZhewen Fan, Lanju Zhang
Biometrics|August 22, 2006
Response-adaptive randomization for clinical trials with continuous outcomesLanju Zhang, William F Rosenberger
American Journal of Physiology. Endocrinology and Metabolism|April 2, 2020
Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver diseaseXiaonan Liu, Shuhong Chen, Lanju Zhang
Journal of Biopharmaceutical Statistics|April 5, 2014
Sample size consideration for immunoassay screening cut-point determinationJianchun Zhang, Lanju Zhang, Harry Yang
Vaccine|March 16, 2010
A probabilistic model for risk assessment of residual host cell DNA in biological productsHarry Yang, Lanju Zhang, Mark Galinski
Journal of Biopharmaceutical Statistics|January 8, 2009
Test homogeneity of risk difference across subgroups in clinical trialsLanju Zhang, Harry Yang, Iksung Cho
Pharmaceutical Development and Technology|November 12, 2014
Risk management for moisture related effects in dry manufacturing processes: a statistical approachJorge Quiroz, John Strong, Lanju Zhang
Contemporary Clinical Trials|April 30, 2017
Optimal adaptive group sequential design with flexible timing of sample size determinationLu Cui, Lanju Zhang, Bo Yang
Statistics in Medicine|March 22, 2016
Optimal flexible sample size design with robust powerLanju Zhang, Lu Cui, Bo Yang
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Statistics in Medicine|November 20, 2018
On the efficiency of adaptive sample size designLu Cui, Lanju Zhang
Journal of Biopharmaceutical Statistics|October 31, 2014
One- and two-stage Arrhenius models for pharmaceutical shelf life predictionZhewen Fan, Lanju Zhang
Biometrics|August 22, 2006
Response-adaptive randomization for clinical trials with continuous outcomesLanju Zhang, William F Rosenberger
American Journal of Physiology. Endocrinology and Metabolism|April 2, 2020
Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver diseaseXiaonan Liu, Shuhong Chen, Lanju Zhang
Journal of Biopharmaceutical Statistics|April 5, 2014
Sample size consideration for immunoassay screening cut-point determinationJianchun Zhang, Lanju Zhang, Harry Yang
Vaccine|March 16, 2010
A probabilistic model for risk assessment of residual host cell DNA in biological productsHarry Yang, Lanju Zhang, Mark Galinski
Journal of Biopharmaceutical Statistics|January 8, 2009
Test homogeneity of risk difference across subgroups in clinical trialsLanju Zhang, Harry Yang, Iksung Cho
Pharmaceutical Development and Technology|November 12, 2014
Risk management for moisture related effects in dry manufacturing processes: a statistical approachJorge Quiroz, John Strong, Lanju Zhang
Contemporary Clinical Trials|April 30, 2017
Optimal adaptive group sequential design with flexible timing of sample size determinationLu Cui, Lanju Zhang, Bo Yang
Statistics in Medicine|March 22, 2016
Optimal flexible sample size design with robust powerLanju Zhang, Lu Cui, Bo Yang
Pageof 4